CoChat
Sign Up
Cited by 120

In-Depth Characterization of the MicroRNA Transcriptome in Normal Thyroid and Papillary Thyroid Carcinoma

Swierniak, Michal, Wojcicka, Anna, Czetwertynska, Malgorzata, Stachlewska, Elzbieta, Maciag, Monika, Wiechno, Wieslaw, Gornicka, Barbara, Bogdanska, Magdalena +3 more·2013·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2013-1214
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-1214

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miR-144 has been found highly expressed in normal thyroid and downregulated in papillary thyroid carcinoma (18).

    “Of note, miR-144 has been found highly expressed in normal thyroid and downregulated in papillary thyroid carcinoma (18).”

    From Distribution of miRNA expression across human tissues (2016) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988 -2005. Cancer. 2009;115: 3801-3807.
  2. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic ap- proaches. Cancer Epidemiol Biomarkers Prev. 2001;10:733-741.
  3. Frich L, Glattre E, Akslen LA. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree rela- tives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev. 2001;10:113-117.
  4. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009;41:460 -464.
  5. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012;44:319 -322.
  6. Jendrzejewski J, He H, Radomska HS, et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci USA. 2012;109:8646 -8651.
  7. He H, Nagy R, Liyanarachchi S, et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 2009;69:625-631.
  8. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, Burge CB. Determinants of targeting by endogenous and exogenous mi- croRNAs and siRNAs. RNA. 2007;13:1894 -1910.
  9. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102-114.
  10. Bartel DP. MicroRNAs: target recognition and regulatory func- tions. Cell. 2009;136:215-233.
  11. Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol. 2006;342:129 -138.
  12. Starega-Roslan J, Krol J, Koscianska E, et al. Structural basis of microRNA length variety. Nucleic Acids Res. 2011;39:257-268.
  13. Chiang HR, Schoenfeld LW, Ruby JG, et al. Mammalian microR- NAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 2010;24:992-1009.
  14. Frank F, Sonenberg N, Nagar B. Structural basis for 5Ј-nucleotide base-specific recognition of guide RNA by human AGO2. Nature. 2010;465:818 -822.
  15. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2008;122:969 -977.
  16. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mR- NAs. Nature. 2005;433:769.
  17. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834 -838.
  18. Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expres- sion in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1919 -1928.
  19. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269 -7274.
  20. Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a con- tribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106:1502- 1505.
  21. Jazdzewski K, de la Chapelle A. Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic. Cell Cycle. 2009;8: 1642-1643.
  22. de la Chapelle A, Jazdzewski K. MicroRNAs in thyroid cancer. J Clin Endocrinol Metab. 2011;96:3326 -3336.
  23. He H, Jazdzewski K, Liyanarachchi S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2005;102:19075-19080.
  24. Pallante P, Visone R, Ferracin M, et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer. 2006; 13:497-508.
  25. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA. 2004;101:9740 -9744.
  26. Pichler M, Balic M, Stadelmeyer E, et al. Evaluation of high-reso- lution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors. J Mol Diagn. 2009;11:140 - 147.
  27. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morpholog- ical variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997;57:1690 -1694.
  28. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39: D152-D157.
  29. Martin MM. Cutadapt removes adaptor sequences from high- throughput sequencing reads. EMBnet.journal. 2011;17:1.
  30. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and mem- ory-efficient alignment of short DNA sequences to the human ge- nome. Genome Biol. 2009;10:R25.
  31. Cloonan N, Grimmond SM. Transcriptome content and dynamics at single-nucleotide resolution. Genome Biol. 2008;9:234.
  32. Morin RD, O'Connor MD, Griffith M, et al. Application of mas- sively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18:610 -621.
  33. Kuchenbauer F, Morin RD, Argiropoulos B, et al. In-depth char- acterization of the microRNA transcriptome in a leukemia progres- sion model. Genome Res. 2008;18:1787-1797.
  34. Farazi TA, Horlings HM, Ten Hoeve JJ, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011;71:4443-4453.
  35. Szczyrba J, Loprich E, Wach S, et al. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res. 2010;8:529 -538.
  36. Han Y, Chen J, Zhao X, et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 2011;6: e18286.

Cited by

Sorted by citations

Authors
Swierniak, M., Wojcicka, A., Czetwertynska, M., Stachlewska, E., Maciag, M., Wiechno, W., Gornicka, B., Bogdanska, M., Koperski, L., de la Chapelle, A., & Jazdzewski, K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2013-08
Volume
98
Issue
8
Pages
E1401-E1409
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/jc.2013-1214
Cited by
120
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review